Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2018 | 2 |
2019 | 1 |
2020 | 1 |
2021 | 1 |
2024 | 0 |
Search Results
5 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Oxazaphosphorine cytostatics: from serendipity to rational drug design.
Anticancer Drugs. 2019 Jun;30(5):435-440. doi: 10.1097/CAD.0000000000000782.
Anticancer Drugs. 2019.
PMID: 30855309
Review.
Causes and possibilities to circumvent cyclophosphamide toxicity.
Voelcker G.
Voelcker G.
Anticancer Drugs. 2020 Jul;31(6):617-622. doi: 10.1097/CAD.0000000000000912.
Anticancer Drugs. 2020.
PMID: 32044797
Item in Clipboard
Aldophosphamide-thiazolidine (NSC-613060) an oxazaphosphorine cytostatic that crosses the blood brain barrier.
Voelcker G.
Voelcker G.
Anticancer Drugs. 2021 Jan 1;32(1):61-65. doi: 10.1097/CAD.0000000000000974.
Anticancer Drugs. 2021.
PMID: 32701559
Item in Clipboard
Influence of the alkylating function of aldo-Ifosfamide on the anti-tumor activity.
Voelcker G.
Voelcker G.
Anticancer Drugs. 2018 Jan;29(1):75-79. doi: 10.1097/CAD.0000000000000569.
Anticancer Drugs. 2018.
PMID: 29219879
Item in Clipboard
Immunostimulating and cancer-reductive experimental therapy with the oxazaphosphorine cytostatic SUM-IAP.
Voelcker G.
Voelcker G.
Anticancer Drugs. 2018 Jun;29(5):411-415. doi: 10.1097/CAD.0000000000000608.
Anticancer Drugs. 2018.
PMID: 29465464
Item in Clipboard
Cite
Cite